Subjects: ANTICORPOS ANTIFOSFOLIPÍDEOS, COVID-19, PACIENTES INTERNADOS, VITAMINA D
ABNT
SALES, Lucas P. et al. Effect of vitamin D3 on antiphospholipid antibodies in hospitalized patients with moderate to severe COVID-19. Clinics, v. 79, 2024Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/79440. Acesso em: 13 nov. 2025.APA
Sales, L. P., Souza, L. V. B., Fernandes, A. L., Murai, I. H., Santos, M. D., Vendramini, M. B. G., et al. (2024). Effect of vitamin D3 on antiphospholipid antibodies in hospitalized patients with moderate to severe COVID-19. Clinics, 79. doi:10.1016/j.clinsp.2024.100474NLM
Sales LP, Souza LVB, Fernandes AL, Murai IH, Santos MD, Vendramini MBG, Oliveira RM, Figueiredo CP, Caparbo VF, Gualano B. Effect of vitamin D3 on antiphospholipid antibodies in hospitalized patients with moderate to severe COVID-19 [Internet]. Clinics. 2024 ; 79[citado 2025 nov. 13 ] Available from: https://observatorio.fm.usp.br/handle/OPI/79440Vancouver
Sales LP, Souza LVB, Fernandes AL, Murai IH, Santos MD, Vendramini MBG, Oliveira RM, Figueiredo CP, Caparbo VF, Gualano B. Effect of vitamin D3 on antiphospholipid antibodies in hospitalized patients with moderate to severe COVID-19 [Internet]. Clinics. 2024 ; 79[citado 2025 nov. 13 ] Available from: https://observatorio.fm.usp.br/handle/OPI/79440
